Ticagrelor is a cornerstone of dual antiplatelet therapy (DAPT) post-percutaneous coronary intervention (PCI), but resistance is rarely reported and poorly understood. We present a case of a 51-year-old woman with type 2 diabetes and a family history of corona... ...

请注册登录后继续浏览